January 20, 2015
Sanofi K.K. launched on January 19 its antiallergenic treatment Allegra dry syrup 5% (fexofenadine). The drug is indicated for allergic rhinitis, urticarial, and itching associated with dermatological diseases (eczema, dermatitis, dermal pruritus, and atopic dermatitis) in infants and children aged...read more